Navigating regulatory fragmentation in the convergence of synthetic biology, artificial intelligence, and automation - Nature

As AI and genetic engineering become more powerful, regulators around the world are struggling to set consistent rules. This matters because gaps in oversight could allow dangerous applications while overly strict rules might slow beneficial innovation.